Live Breaking News & Updates on Drug Discovery Intelligence

Stay updated with breaking news from Drug discovery intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Clarivate Acquires Bioinfogate, Reinforcing Position as Premier Provider of End-to-End Research Intelligence Solutions for Life Sciences


Share this article
Share this article
Expanding and integrating drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle, allowing customers to make more informed decisions 
LONDON, Aug. 4, 2021 /PRNewswire/  Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it has acquired
 Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the OFF-X™ portal. Financial terms of the transaction were not disclosed.   
The Bioinfogate OFF-X™ portal is a cutting-edge safety intelligence solution aimed at empowering pharmaceutical organizations to identify toxicology and safety signals, mitigate safety liabilities and de-risk early-stage assets. It is one of the largest translational safety and toxicity portals, featuring over 1,200,000 safety alerts correspondin ....

City Of , United Kingdom , Tabita Seagrave , Josep Prous , Mark Donohue , David Prous , Mukhtar Ahmed , Prous Institute For Biomedical Research , Exchange Commission , Thomson Reuters , Science Group , Decision Resources Group , Clarivate Plc , Head Of Global Corporate Communications , Drug Discovery Intelligence , Prous Science , Drug Discovery , Competitive Intelligence , Executive Director , Prous Institute , Private Securities Litigation Reform Act , Global Corporate Communications , Investor Relations , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , குறி தோனொுே ,